CN103536874A - Medicine for treating superficial gastritis - Google Patents
Medicine for treating superficial gastritis Download PDFInfo
- Publication number
- CN103536874A CN103536874A CN201310463416.2A CN201310463416A CN103536874A CN 103536874 A CN103536874 A CN 103536874A CN 201310463416 A CN201310463416 A CN 201310463416A CN 103536874 A CN103536874 A CN 103536874A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- rhizoma
- radix
- superficial gastritis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicine for treating superficial gastritis. The medicine is a medicament prepared from the following active ingredients in parts by weight: 18-22 parts of pericarpium arecae, 20-25 parts of costustoot, 20-25 parts of rhizoma coptidis, 13-16 parts of astragalus membranaceus, 11-15 parts of poria cocos, 7-9 parts of pinellia ternate, 5-7 parts of ginger, 16-19 parts of rhizoma atractylodis macrocephalae, 13-17 parts of purple perilla, 11-15 parts of pericarpium citri reticulatae, 6-9 parts of agilawood, 8-12 parts of mulberry, 6-10 parts of platycladi seed, 6-10 parts of folium cortex eucommiae, 17-20 parts of dichondra repens forst, 9-12 parts of radix bupleuri, 5-9 parts of acanthopanax root, 4-9 parts of bark of Chinese redbud, and 6-8 parts of sambucus chinensis. The medicament disclosed by the invention is used for treating superficial gastritis by synchronously nursing from internal organs, the stimulation of western medicine to the gastric mucosa is prevented, the effect is good, the cure rate is high, and the superficial gastritis has small possibility of relapse.
Description
Technical field
The present invention relates to treat the Chinese medicine of gastropathy, particularly a kind of medicine for the treatment of superficial gastritis.
Background technology
Chronic superficial gastritis refers to that gastric mucosa is chronic superficial inflammation, it is the most common a kind of in chronic gastritis, its pathogenic factor differs, can be because being addicted to drink, drink espresso, or because of bile reflux, or cause because of helicobacter pylori infections etc., this disease is a commonly encountered diseases, frequently-occurring disease, men and women, old and young all can suffer from, most of superficial gastritis patients lack clinical symptoms, some patients were often has epigastrium feeling of distension and oppression, belch, acid regurgitation, loss of appetite, or irregular upper abdomen dull pain, food postemphasis etc., the course of disease of superficial gastritis is long, easily recurrence, very heavy to health effect, modern medicine does not still have effect method to the treatment of chronic superficial gastritis, the effect of a lot of Therapeutic Method is unstable, more easily recurrence after.
Summary of the invention
The object of this invention is to provide a kind of good effect, be difficult for more afterwards the Chinese medicine of the treatment chronic superficial gastritis of recurrence.
For solving the problems of the technologies described above, the present invention adopts following technical scheme:
Treat a medicine for superficial gastritis, it is the medicament of being made by weight by following bulk drugs: Pericarpium Arecae 18-22 part, Radix Aucklandiae 20-25 part, Rhizoma Coptidis 20-25 part, Radix Astragali 13-16 part, Poria 11-15 part, Rhizoma Pinelliae 7-9 part, Rhizoma Zingiberis Recens 5-7 part, Rhizoma Atractylodis Macrocephalae 16-19 part, Folium Perillae 13-17 part, Pericarpium Citri Reticulatae 11-15 part, Lignum Aquilariae Resinatum 6-9 part, Fructus Mori 8-12 part, Semen Platycladi 6-10 part, Folium Eucommiae 6-10 part, Herba Lysimachiae 17-20 part, Radix Bupleuri 9-12 part, Radix Et Caulis Acanthopanacis Senticosi 5-9 part, Cortex cercis chinensis 4-9 part, Herba Sambuci Chiensis 6-8 part.
Preferably, it is the medicament of being made by weight by following bulk drugs: 20 parts of Pericarpium Arecae, 22 parts of the Radix Aucklandiae, 23 parts of Rhizoma Coptidis, 15 parts of the Radixs Astragali, 13 parts, Poria, 8 parts of the Rhizoma Pinelliaes, 6 parts, Rhizoma Zingiberis Recens, 18 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts of Folium Perillaes, 13 parts of Pericarpium Citri Reticulataes, 8 parts of Lignum Aquilariae Resinatum, 10 parts of Fructus Mori, 8 parts of Semen Platycladi, 8 parts of Folium Eucommiaes, 18 parts of Herba Lysimachiaes, 11 parts of Radix Bupleuri, 7 parts of Radix Et Caulis Acanthopanacis Senticosis, 7 parts of Cortex cercis chinensiss, 7 parts of Herba Sambuci Chiensis.
Preferably, described medicament is a kind of decoction.
Pharmacology and the effect of the medical material that the present invention chooses are respectively:
Pericarpium Arecae: acrid in the mouth, slightly warm in nature, returns spleen, stomach, large intestine, small intestine meridian, and Xin Nenghang is loose, and master enters taste warp, and energy circulation of qi promoting intestinal stasis relieving, is the prompt medicine of alleviating distention in middle-JIAO promoting the circulation of QI.The gastral cavity abdomen painful abdominal mass of controlling stagnation of QI due to dyspepsia is swollen, belch acid regurgitation.
The Radix Aucklandiae: acrid in the mouth is bitter, warm in nature, returns spleen, large intestine, tri-jiao channel, Xin Wenxiang is loose, can rise and can fall, and leads to the gas of managing three warmers, and the especially gas of benefaction gastrointestinal and pain relieving has the merit of strengthening the spleen to promote digestion concurrently, and all cards are conventional product due to all taste QI stagnation of the large intestine, join Rhizoma Coptidis.
The Radix Astragali: sweet in the mouth, slightly warm in nature, returns liver, spleen, lung, kidney channel, has the effect that benefiting QI for strengthening the superficies, arresting sweating are admittedly de-, hold in the palm skin ulcer granulation promoting, inducing diuresis to remove edema.
Poria: sweet in the mouth, property is light flat, GUIXIN warp, lung meridian, spleen channel, kidney channel, in deficiency of spleen-QI person, can with the compatibility such as the Radix Astragali, the Rhizoma Atractylodis Macrocephalae.
The Rhizoma Pinelliae: its acrid in the mouth, warm in nature, poisonous, return spleen, stomach, lung meridian, the toxicity that Rhizoma Zingiberis Recens can subtract, can control damp-phlegm cold drink, vomiting, regurgitation, cough with asthma abundant expectoration, chest and diaphragm distension, syncope due to accumulation of phlegm headache, dizzy sleeplessness.
Folium Perillae: acrid in the mouth warm in nature, have induce sweat, cold expelling, the effect of regulating the flow of vital energy and seeking, be applicable to the diseases such as cold, fever with aversion to cold, cough, asthma, distension and fullness of the chest and abdomen.
Pericarpium Citri Reticulatae: acrid in the mouth warm in nature, return lung, spleen channel, regulating qi-flowing for strengthening spleen, drying dampness to eliminate phlegm, for fullness in the epigastrium and chest, lack of appetite and vomiting, cough with copious phlegm.
Lignum Aquilariae Resinatum: acrid in the mouth warm in nature, return spleen, stomach, kidney, lung meridian, join the Radix Aucklandiae, QI invigorating circulation of qi promoting, controls cold air and attacks the weak appetite of centre of punch Fu Xu pain taste element easily to hinder vomiting cold phlegm spirit unclear.
Fructus Mori: sweet in the mouth is cold in nature, return liver, kidney channel, nourishing YIN and benefiting blood, the intestine moistening of promoting the production of body fluid, strengthening the spleen and stomach, aid digestion.
Semen Platycladi: sweet in the mouth is flat.GUIXIN, kidney, large intestine channel, property is flat and cold not dry, sweet in the mouth and mending, Xin Erneng profit, its gas delicate fragrance, heart kidney thoroughly, strengthening the spleen stomach, also, agent that should nourishing is used it to the product medicine of covering.
Folium Eucommiae: acrid in the mouth is warm in nature.Return liver, kidney channel, sedation and analgesia, invigorating the liver and kidney, bone and muscle strengthening.
Herba Lysimachiae: sweet in the mouth, micro-hardship, cool in nature, return liver, gallbladder, kidney, urinary bladder channel, there is calculus, antibacterial, antiinflammatory action
Radix Bupleuri: bitter in the mouth, pungent, cold nature, returns Liver Channel, gallbladder meridian, tool depressed liver-energy dispersing and function of gallbladder promoting, thin gas resolving depression, loose effect of fire.
Radix Et Caulis Acanthopanacis Senticosi: acrid in the mouth, hardship, micro-sweet, warm in nature, return Liver Channel; Kidney channel, for wind-damp dispelling, invigorating the liver and kidney, bone and muscle strengthening, invigorate blood circulation.
Cortex cercis chinensis: bitter in the mouth, warm in nature, return liver, spleen two warps, tool anti-inflammatory and antalgic, blood-activating and qi-promoting, the effect of subduing swelling and detoxicating.
Herba Sambuci Chiensis: bitter in the mouth, warm in nature, enter liver, kidney two warps, for promoting blood circulation to remove blood stasis, soothing liver and strengthening spleen, dispelling, collateral-activating.
Preparation and instructions of taking are: every day potion, decocting, filter and remove residue, at twice, sooner or later takes.
The Chinese medicine ingredients of a kind of medicine for the treatment of superficial gastritis provided by the present invention is simple, can nourishing the stomach stomach function regulating, cost is low and can effectively treat superficial gastritis, is difficult for more afterwards recurrence.
The specific embodiment
Below in conjunction with the specific embodiment, further describe the present invention, to make those skilled in the art can implement according to this with reference to description word, but be to be understood that protection scope of the present invention is not subject to the restriction of the specific embodiment.
Embodiment 1
Treat a medicine for superficial gastritis, it is the medicament of being made by weight by following bulk drugs: 20 parts of Pericarpium Arecae, 22 parts of the Radix Aucklandiae, 23 parts of Rhizoma Coptidis, 15 parts of the Radixs Astragali, 13 parts, Poria, 8 parts of the Rhizoma Pinelliaes, 6 parts, Rhizoma Zingiberis Recens, 18 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts of Folium Perillaes, 13 parts of Pericarpium Citri Reticulataes, 8 parts of Lignum Aquilariae Resinatum, 10 parts of Fructus Mori, 8 parts of Semen Platycladi, 8 parts of Folium Eucommiaes, 18 parts of Herba Lysimachiaes, 11 parts of Radix Bupleuri, 7 parts of Radix Et Caulis Acanthopanacis Senticosis, 7 parts of Cortex cercis chinensiss, 7 parts of Herba Sambuci Chiensis.
According to this drug weight proportioning, weighting raw materials, decocting, filter and remove residue, takes at twice, sooner or later once, within 15th, is a course for the treatment of.
Below in conjunction with clinical setting and typical case, treat and add up to illustrate its beneficial effect.
1, physical data
Accept out-patient's 100 examples for medical treatment, male's 57 examples wherein, female patient 43 examples, 38 years old mean age.
2, diagnostic criteria
Persistence epigastric discomfort or pain at random, or glutted after food, and inappetence, feels sick, acid regurgitation, belch, constipation.
3, Therapeutic Method
According to drug weight proportioning of the present invention, weighting raw materials, every day potion, decocting, filter and remove residue, takes at twice, sooner or later once, within 15th, is a course for the treatment of.
4, therapeutic outcome statistics
After treatment, by following up a case by regular visits to, recurrence rate after healing is 3.5%.
Typical case 1:
Lee, man, 51 years old, persistence epigastric discomfort or pain at random, inappetence, acid regurgitation, belch, ill 8 years, adopt multiple existing western medicines in treatment, or poor effect, or occur repeatedly, cannot effect a radical cure.
Take after the medicine that provide by above drug weight proportioning a kind of treat superficial gastritis, after 2 courses for the treatment of, thoroughly rehabilitation, follows up a case by regular visits to and has no recurrence.
Typical case 2:
Beam, female, 47 years old, epigastrium feeling of distension and oppression, dull pain, belch, acid regurgitation, constipation, heavy when light during symptom, ill 6 years, special prescription of Chinese herbal medicine was found in hospital treatment or many places, all cannot effect a radical cure.
Take after the medicine that provide by above drug weight proportioning a kind of treat superficial gastritis, be clearly better 1 course for the treatment of, and two the thorough rehabilitations course for the treatment of, follow up a case by regular visits to and have no recurrence.
Embodiment 2
Treat a medicine for superficial gastritis, it is the medicament of being made by weight by following bulk drugs: 18 parts of Pericarpium Arecae, 20 parts of the Radix Aucklandiae, 20 parts of Rhizoma Coptidis, 16 parts of the Radixs Astragali, 15 parts, Poria, 7 parts of the Rhizoma Pinelliaes, 5 parts, Rhizoma Zingiberis Recens, 19 parts of the Rhizoma Atractylodis Macrocephalaes, 13 parts of Folium Perillaes, 15 parts of Pericarpium Citri Reticulataes, 9 parts of Lignum Aquilariae Resinatum, 12 parts of Fructus Mori, 6 parts of Semen Platycladi, 10 parts of Folium Eucommiaes, 17 parts of Herba Lysimachiaes, 12 parts of Radix Bupleuri, 5 parts of Radix Et Caulis Acanthopanacis Senticosis, 9 parts of Cortex cercis chinensiss, 6 parts of Herba Sambuci Chiensis.
According to this drug weight proportioning, weighting raw materials, decocting, filter and remove residue, takes at twice, sooner or later once, within 15th, is a course for the treatment of.
Get 100 cases of the clinical setting identical with embodiment 1 and treat and add up, gained therapeutic outcome is as follows:
After treatment, by following up a case by regular visits to, recurrence rate after healing is 4.7%
Embodiment 3
Treat a medicine for superficial gastritis, it is the medicament of being made by weight by following bulk drugs: 22 parts of Pericarpium Arecae, 25 parts of the Radix Aucklandiae, 25 parts of Rhizoma Coptidis, 13 parts of the Radixs Astragali, 11 parts, Poria, 9 parts of the Rhizoma Pinelliaes, 7 parts, Rhizoma Zingiberis Recens, 16 parts of the Rhizoma Atractylodis Macrocephalaes, 17 parts of Folium Perillaes, 11 parts of Pericarpium Citri Reticulataes, 6 parts of Lignum Aquilariae Resinatum, 8 parts of Fructus Mori, 10 parts of Semen Platycladi, 6 parts of Folium Eucommiaes, 20 parts of Herba Lysimachiaes, 9 parts of Radix Bupleuri, 9 parts of Radix Et Caulis Acanthopanacis Senticosis, 4 parts of Cortex cercis chinensiss, 8 parts of Herba Sambuci Chiensis.
According to this drug weight proportioning, weighting raw materials, decocting, filter and remove residue, takes at twice, sooner or later once, within 15th, is a course for the treatment of.
Get 100 cases of the clinical setting identical with embodiment 1 and treat and add up, gained therapeutic outcome is as follows:
After treatment, by following up a case by regular visits to, recurrence rate after healing is 4.3%.
Claims (3)
1. a medicine for the treatment of superficial gastritis, it is characterized in that: it is the medicament of being made by weight by following bulk drugs: Pericarpium Arecae 18-22 part, Radix Aucklandiae 20-25 part, Rhizoma Coptidis 20-25 part, Radix Astragali 13-16 part, Poria 11-15 part, Rhizoma Pinelliae 7-9 part, Rhizoma Zingiberis Recens 5-7 part, Rhizoma Atractylodis Macrocephalae 16-19 part, Folium Perillae 13-17 part, Pericarpium Citri Reticulatae 11-15 part, Lignum Aquilariae Resinatum 6-9 part, Fructus Mori 8-12 part, Semen Platycladi 6-10 part, Folium Eucommiae 6-10 part, Herba Lysimachiae 17-20 part, Radix Bupleuri 9-12 part, Radix Et Caulis Acanthopanacis Senticosi 5-9 part, Cortex cercis chinensis 4-9 part, Herba Sambuci Chiensis 6-8 part.
2. the medicine for the treatment of superficial gastritis according to claim 1, it is characterized in that: it is the medicament of being made by weight by following bulk drugs: 20 parts of Pericarpium Arecae, 22 parts of the Radix Aucklandiae, 23 parts of Rhizoma Coptidis, 15 parts of the Radixs Astragali, 13 parts, Poria, 8 parts of the Rhizoma Pinelliaes, 6 parts, Rhizoma Zingiberis Recens, 18 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts of Folium Perillaes, 13 parts of Pericarpium Citri Reticulataes, 8 parts of Lignum Aquilariae Resinatum, 10 parts of Fructus Mori, 8 parts of Semen Platycladi, 8 parts of Folium Eucommiaes, 18 parts of Herba Lysimachiaes, 11 parts of Radix Bupleuri, 7 parts of Radix Et Caulis Acanthopanacis Senticosis, 7 parts of Cortex cercis chinensiss, 7 parts of Herba Sambuci Chiensis.
3. according to the medicine of the treatment superficial gastritis described in claims 1 or 2, it is characterized in that: described medicament is a kind of decoction.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310463416.2A CN103536874A (en) | 2013-10-08 | 2013-10-08 | Medicine for treating superficial gastritis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310463416.2A CN103536874A (en) | 2013-10-08 | 2013-10-08 | Medicine for treating superficial gastritis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103536874A true CN103536874A (en) | 2014-01-29 |
Family
ID=49960988
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310463416.2A Pending CN103536874A (en) | 2013-10-08 | 2013-10-08 | Medicine for treating superficial gastritis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103536874A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101607061A (en) * | 2008-06-20 | 2009-12-23 | 天科仁祥技术（北京）有限责任公司 | A kind of drug regimen of protecting gastric mucosa and preparation method thereof |
| CN102935199A (en) * | 2012-11-27 | 2013-02-20 | 殷晓娜 | Chinese medicinal composition for treating chronic gastritis |
-
2013
- 2013-10-08 CN CN201310463416.2A patent/CN103536874A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101607061A (en) * | 2008-06-20 | 2009-12-23 | 天科仁祥技术（北京）有限责任公司 | A kind of drug regimen of protecting gastric mucosa and preparation method thereof |
| CN102935199A (en) * | 2012-11-27 | 2013-02-20 | 殷晓娜 | Chinese medicinal composition for treating chronic gastritis |
Non-Patent Citations (1)
| Title |
|---|
| 刘赓: "慢性萎缩性胃炎中医证候特征及辨证治疗的疗效研究", 《中国中医科学院2006级博士研究生学位论文》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103705843B (en) | A kind of medicine for the treatment of gastropathy | |
| CN103463587A (en) | Traditional Chinese medicine composition for treating deficiency-cold in spleen and stomach | |
| CN102188685B (en) | Externally-applied traditional Chinese medicine powder for treating diarrhea type irritable bowel syndrome and preparation method thereof | |
| CN103585521B (en) | A kind of Chinese medicine composition being used for the treatment of dyspepsia, eating accumulation | |
| CN102631512B (en) | Traditional Chinese medicine composition for curing chronic colitis | |
| CN104740437A (en) | Traditional Chinese medicine composition for treating constipation and preparation method of traditional Chinese medicine composition | |
| CN104667126A (en) | Traditional Chinese medicinal composition for treating chronic gastritis | |
| CN102008674B (en) | Plaster for treating herniated disk, hyperosteogeny and rheumatoid diseases and preparation method thereof | |
| CN104189759A (en) | Traditional Chinese medicine composition for treating cholelithiasis | |
| CN102949685A (en) | Traditional Chinese medicine composition for treating chronic gastritis | |
| CN103083616B (en) | Traditional Chinese medicine for treating ovarian cyst | |
| CN104001131A (en) | Oral traditional Chinese medicine for preventing and treating stress ulcers | |
| CN103251889A (en) | Traditional Chinese medicine composition for treating agalactia | |
| CN103690870B (en) | Treat damp and hot interior strongly fragrant Chinese medicine and preparation method thereof | |
| CN103394030A (en) | Traditional Chinese medicine composition for treating depressed liver and deficient spleen | |
| CN102895392B (en) | Chinese medicine for treating duodenal ulcer | |
| CN103212013B (en) | Chinese medicinal composition for treating epigastric pain | |
| CN104352899A (en) | Traditional Chinese medicinal preparation for treating chronic gastritis | |
| CN104800772A (en) | Traditional Chinese medicine composition for treating vital-energy-depression type coronary heart disease and application of traditional Chinese medicine composition | |
| CN104383403A (en) | Traditional Chinese medicinal composition for treating chronic gastritis | |
| CN107854662A (en) | A kind of Chinese medicine preparation for treating cirrhotic ascites and preparation method thereof | |
| CN102451328A (en) | Chinese medicine for treating gastric ulcer | |
| CN103536874A (en) | Medicine for treating superficial gastritis | |
| CN105435042A (en) | Traditional Chinese medicine health care unguent | |
| CN101129537A (en) | Orally taken traditional Chinese medicine composition for treating irritable bowel syndrome |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140129 |